IE880354L - Sustained release dosage form - Google Patents

Sustained release dosage form

Info

Publication number
IE880354L
IE880354L IE35488A IE35488A IE880354L IE 880354 L IE880354 L IE 880354L IE 35488 A IE35488 A IE 35488A IE 35488 A IE35488 A IE 35488A IE 880354 L IE880354 L IE 880354L
Authority
IE
Ireland
Prior art keywords
dosage form
sustained release
release dosage
sustained
release
Prior art date
Application number
IE35488A
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Priority to IE35488A priority Critical patent/IE880354L/en
Publication of IE880354L publication Critical patent/IE880354L/en

Links

IE35488A 1988-02-09 1988-02-09 Sustained release dosage form IE880354L (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IE35488A IE880354L (en) 1988-02-09 1988-02-09 Sustained release dosage form

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IE35488A IE880354L (en) 1988-02-09 1988-02-09 Sustained release dosage form

Publications (1)

Publication Number Publication Date
IE880354L true IE880354L (en) 1988-09-09

Family

ID=11011052

Family Applications (1)

Application Number Title Priority Date Filing Date
IE35488A IE880354L (en) 1988-02-09 1988-02-09 Sustained release dosage form

Country Status (1)

Country Link
IE (1) IE880354L (en)

Similar Documents

Publication Publication Date Title
GB2218905B (en) Controlled release pharmaceutical
AR243378A1 (en) Sustained release pharmaceutical composition
GB2210266B (en) Dosage form
PH24205A (en) Sustained release dosage forms
ZA868039B (en) Sustained release tablets
ZA895838B (en) Pharmaceutical compounds
SG123894G (en) Novel dosage form
ZA89260B (en) Pharmaceutical compounds
GB2176999B (en) Sustained release medicament
EP0443027A4 (en) Drug composition
ZA899948B (en) Pharmaceutical preparation
GB8820242D0 (en) Sustained release device
IE880354L (en) Sustained release dosage form
ZA898127B (en) Dosage form
GB8902424D0 (en) Medicinal formulations
IE872675L (en) Sustained release pharmaceutical
GB8900926D0 (en) Slow and sustained release dosage forms
ZA898470B (en) Sustained release preparations
CS8802913A2 (en) Hyperthyroidism medicament
IE880658L (en) Sustained release compositions
GB8908838D0 (en) Sustained release
ZA898120B (en) Carcinostatic agents
SG27194G (en) Sustained release etodaloc
IE882292L (en) Tablets having improved bioadhesion
GB8816351D0 (en) Sustained drug release system